“…Biochemical, cell biological and transgenic animal studies have suggested several mechanisms to explain apoE4's contribution to the pathogenesis of AD. These include the modulation of the deposition and clearance of Aβ and the formation of plaques [31,33,34,76,86,[128][129][130][131][132][133], impairment of the antioxidative defence system [134][135][136], dysregulation of the neuronal signalling pathways [137][138][139], disruption of cytoskeletal structure and function [113,114,120], increased phosphorylation of tau and the formation of NFTs [56,140], impairment of glucose metabolism and mitochondrial integrity and function [59,[97][98][99][100][101][102][103][104][105][106][107][108][109][110][111] and impairment of GABAergic interneuron function and hippocampal neurogenesis [88,126]. However, the mechanisms of these apoE4-mediated effects are still poorly understood.…”